Reply to the Letter to the Editor regarding ‘PFS, OS or toxicity: what is the most important factor in the treatment of EGFR-mutated lung cancer?’ by T. Nishimura and H. Fujimoto

E. Felip; B. C. Cho; D. Nguyen; J. C. Curtin; S. Sethi; J. M. Bauml; S. H. Lee

doi:10.1016/j.annonc.2024.10.011

Reply to the Letter to the Editor regarding ‘PFS, OS or toxicity: what is the most important factor in the treatment of EGFR-mutated lung cancer?’ by T. Nishimura and H. Fujimoto

E. Felip
, B. C. Cho
, D. Nguyen
, J. C. Curtin
, S. Sethi
, J. M. Bauml
, S. H. Lee

Department of Internal Medicine

Autonomous University of Barcelona
Yonsei University
City of Hope National Med Center
Johnson & Johnson

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	221-222
Number of pages	2
Journal	Annals of Oncology
Volume	36
Issue number	2
DOIs	https://doi.org/10.1016/j.annonc.2024.10.011
State	Published - Feb 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.annonc.2024.10.011

Cite this

@article{03b5fa5eecf94b5ca837e2bd4197e33b,

title = "Reply to the Letter to the Editor regarding {\textquoteleft}PFS, OS or toxicity: what is the most important factor in the treatment of EGFR-mutated lung cancer?{\textquoteright} by T. Nishimura and H. Fujimoto",

author = "E. Felip and Cho, \{B. C.\} and D. Nguyen and Curtin, \{J. C.\} and S. Sethi and Bauml, \{J. M.\} and Lee, \{S. H.\}",

year = "2025",

month = feb,

doi = "10.1016/j.annonc.2024.10.011",

language = "English",

volume = "36",

pages = "221--222",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd",

number = "2",

}

TY - JOUR

T1 - Reply to the Letter to the Editor regarding ‘PFS, OS or toxicity

T2 - what is the most important factor in the treatment of EGFR-mutated lung cancer?’ by T. Nishimura and H. Fujimoto

AU - Felip, E.

AU - Cho, B. C.

AU - Nguyen, D.

AU - Curtin, J. C.

AU - Sethi, S.

AU - Bauml, J. M.

AU - Lee, S. H.

PY - 2025/2

Y1 - 2025/2

UR - https://www.scopus.com/pages/publications/85210093312

U2 - 10.1016/j.annonc.2024.10.011

DO - 10.1016/j.annonc.2024.10.011

M3 - Letter

C2 - 39521680

AN - SCOPUS:85210093312

SN - 0923-7534

VL - 36

SP - 221

EP - 222

JO - Annals of Oncology

JF - Annals of Oncology

IS - 2

ER -

Reply to the Letter to the Editor regarding ‘PFS, OS or toxicity: what is the most important factor in the treatment of EGFR-mutated lung cancer?’ by T. Nishimura and H. Fujimoto

UN SDGs

Access to Document

Other files and links

Cite this